Vaccine Adjuvants Market

The vaccine adjuvants market is projected to reach USD 1.2 Billion by 2028 from USD 0.8 Billion in 2023, at a CAGR of 6.9% during the forecast period. Growth in the vaccine adjuvants market can be attributed to factors such as the collaborations and partnerships among market players for the development of vaccine adjuvants, and increasing number of vaccines launch in the market.

The global vaccine adjuvants market is highly competitive. The prominent players operating in this market include Dynavax Technologies (US), GSK plc (UK), Croda International plc (UK), SEPPIC (France), Novavax (US), SPI Pharma (Associated British Foods plc) (UK), Agenus Inc. (US), Phibro Animal Health Corporation (US), Aurorium (Vertellus) (US), Merck KGaA (Germany), Vaxine Pty Ltd. (Australia), Hawaii Biotech Inc. (US), CSL Limited (Australia), OZ Biosciences (US), InvivoGen (US), and among others.

To know about the assumptions considered for the study download the pdf brochure

Dynavax Technologies (US)

In 2022, Dynavax focuses on inorganic growth strategies to maintain its market position. The company is more focusing on advancing vaccine innovation and Its actively engaged in developing CpG 1018 as a premier vaccine adjuvant through different collaborations and partnerships with biopharmaceutical and biotechnology companies and government bodies. Biological E Limited (India), Clover Biopharmaceuticals (China), Valneva SE (France), and Medigen Vaccine Biologics (China) are some of the company’s partners in vaccine development.

Croda International Plc (UK)

Croda International Plc (UK) is the leading position in the market in 2022. The company has entered into collaborations and partnerships with a number of vaccine developers. Amyris (US) and Botanical Solutions Inc. (BSI) , Danish Government’s Life Science Research Institute (UK), are some of the major partners of the company.

GSK Plc (UK)

GlaxoSmithKline (UK) is also one of the leading player in the market in vaccine adjuvants market. The company focuses on inorganic growth strategies such as partnerships and acquisitions to strengthen its market position. SK Bioscience (South Korea), Bharat Biotech International Limited (India), Affinivax, Inc. (US), and Government of Canada (Canada),are some of the major partners of the company.

Related Reports:

Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), Route of administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Type ( Human vaccine , Veterinary vaccine) - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]